Anbio Biotechnology Class A (NNNN) Stock Statistics & Valuation Metrics

Anbio Biotechnology Class A has a market cap or net worth of $4.68B. The enterprise value is $1.42B.

Anbio Biotechnology Class A has 43,891,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anbio Biotechnology Class A’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 21.59%.

The current PE Ratio of Anbio Biotechnology Class A is 108.6. Anbio Biotechnology Class A’s PEG ratio is 0.98.

In the last 12 months, Anbio Biotechnology Class A had revenue of 9.76M and earned 7.23M in profits. Earnings per share was 0.16.

In the last 12 months, operating cash flow was 2.25M and capital expenditures -2.00, giving a free cash flow of 2.25M billion.

Anbio Biotechnology Class A pays an annual dividend of ―, resulting in a dividend yield of ―

Anbio Biotechnology Class A upcoming earnings date is ―, ―.

Anbio Biotechnology Class A as a current ratio of 344.31, with Debt / Equity ratio of 0.00%

In the past 12 months, Anbio Biotechnology Class A has paid 0.00 in taxes.

Anbio Biotechnology Class A EV to EBITDA ratio is 201.56, with an EV/FCF ratio of -194.69.

Anbio Biotechnology Class A has $11.76M in cash and marketable securities with $0.00 in debt, giving a net cash position of $11.76M billion.

Gross margin is 87.06%, with operating margin of 66.70%, and net profit margin of 74.06%.

The average price target for Anbio Biotechnology Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―